ID   LPIN2_HUMAN             Reviewed;         896 AA.
AC   Q92539; A7MD25; D3DUH3;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   10-MAY-2017, entry version 130.
DE   RecName: Full=Phosphatidate phosphatase LPIN2;
DE            EC=3.1.3.4;
DE   AltName: Full=Lipin-2;
GN   Name=LPIN2; Synonyms=KIAA0249;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=17158099; DOI=10.1074/jbc.M610745200;
RA   Donkor J., Sariahmetoglu M., Dewald J., Brindley D.N., Reue K.;
RT   "Three mammalian lipins act as phosphatidate phosphatases with
RT   distinct tissue expression patterns.";
RL   J. Biol. Chem. 282:3450-3457(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; SER-243 AND
RP   SER-303, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-566, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   VARIANT MJDS LEU-734, AND TISSUE SPECIFICITY.
RX   PubMed=15994876; DOI=10.1136/jmg.2005.030759;
RA   Ferguson P.J., Chen S., Tayeh M.K., Ochoa L., Leal S.M., Pelet A.,
RA   Munnich A., Lyonnet S., Majeed H.A., El-Shanti H.;
RT   "Homozygous mutations in LPIN2 are responsible for the syndrome of
RT   chronic recurrent multifocal osteomyelitis and congenital
RT   dyserythropoietic anaemia (Majeed syndrome).";
RL   J. Med. Genet. 42:551-557(2005).
CC   -!- FUNCTION: Plays important roles in controlling the metabolism of
CC       fatty acids at different levels. Acts as a magnesium-dependent
CC       phosphatidate phosphatase enzyme which catalyzes the conversion of
CC       phosphatidic acid to diacylglycerol during triglyceride,
CC       phosphatidylcholine and phosphatidylethanolamine biosynthesis in
CC       the reticulum endoplasmic membrane. Acts also as a nuclear
CC       transcriptional coactivator for PPARGC1A to modulate lipid
CC       metabolism (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: A 1,2-diacylglycerol 3-phosphate + H(2)O = a
CC       1,2-diacyl-sn-glycerol + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Inhibited by N-ethylmaleimide. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm, cytosol
CC       {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}.
CC       Note=Translocates to endoplasmic reticulum membrane with
CC       increasing levels of oleate. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver, lung, kidney, placenta,
CC       spleen, thymus, lymph node, prostate, testes, small intestine, and
CC       colon. {ECO:0000269|PubMed:15994876, ECO:0000269|PubMed:17158099}.
CC   -!- DOMAIN: Contains 1 Asp-Xaa-Asp-Xaa-Thr (DXDXT) motif, a catalytic
CC       motif known to be essential for phosphatidate phosphatase
CC       activity. {ECO:0000250}.
CC   -!- DOMAIN: Contains one Leu-Xaa-Xaa-Ile-Leu (LXXIL) motif, a motif
CC       known to be a transcriptional binding motif. {ECO:0000250}.
CC   -!- DISEASE: Majeed syndrome (MJDS) [MIM:609628]: An autosomal
CC       recessive syndrome characterized by chronic recurrent multifocal
CC       osteomyelitis that is of early onset with a lifelong course,
CC       congenital dyserythropoietic anemia that presents as hypochromic,
CC       microcytic anemia during the first year of life and ranges from
CC       mild to transfusion-dependent, and transient inflammatory
CC       dermatosis, often manifesting as Sweet syndrome (neutrophilic skin
CC       infiltration). {ECO:0000269|PubMed:15994876}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the lipin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13380.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=INFEVERS; Note=Repertory of FMF and hereditary
CC       autoinflammatory disorders mutations;
CC       URL="http://fmf.igh.cnrs.fr/ISSAID/infevers/search.php?n=7";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D87436; BAA13380.2; ALT_INIT; mRNA.
DR   EMBL; CH471113; EAX01686.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01687.1; -; Genomic_DNA.
DR   EMBL; BC152448; AAI52449.1; -; mRNA.
DR   CCDS; CCDS11829.1; -.
DR   RefSeq; NP_055461.1; NM_014646.2.
DR   RefSeq; XP_005258235.1; XM_005258178.3.
DR   RefSeq; XP_005258236.1; XM_005258179.4.
DR   RefSeq; XP_016881587.1; XM_017026098.1.
DR   RefSeq; XP_016881588.1; XM_017026099.1.
DR   UniGene; Hs.132342; -.
DR   ProteinModelPortal; Q92539; -.
DR   BioGrid; 115019; 3.
DR   IntAct; Q92539; 2.
DR   STRING; 9606.ENSP00000261596; -.
DR   DEPOD; Q92539; -.
DR   iPTMnet; Q92539; -.
DR   PhosphoSitePlus; Q92539; -.
DR   BioMuta; LPIN2; -.
DR   DMDM; 2495724; -.
DR   EPD; Q92539; -.
DR   MaxQB; Q92539; -.
DR   PaxDb; Q92539; -.
DR   PeptideAtlas; Q92539; -.
DR   PRIDE; Q92539; -.
DR   DNASU; 9663; -.
DR   Ensembl; ENST00000261596; ENSP00000261596; ENSG00000101577.
DR   GeneID; 9663; -.
DR   KEGG; hsa:9663; -.
DR   UCSC; uc002klo.3; human.
DR   CTD; 9663; -.
DR   DisGeNET; 9663; -.
DR   GeneCards; LPIN2; -.
DR   GeneReviews; LPIN2; -.
DR   HGNC; HGNC:14450; LPIN2.
DR   HPA; CAB015223; -.
DR   HPA; HPA017857; -.
DR   HPA; HPA030550; -.
DR   MalaCards; LPIN2; -.
DR   MIM; 605519; gene.
DR   MIM; 609628; phenotype.
DR   neXtProt; NX_Q92539; -.
DR   OpenTargets; ENSG00000101577; -.
DR   Orphanet; 77297; Majeed syndrome.
DR   PharmGKB; PA30437; -.
DR   eggNOG; KOG2116; Eukaryota.
DR   eggNOG; COG5083; LUCA.
DR   GeneTree; ENSGT00390000011286; -.
DR   HOGENOM; HOG000230954; -.
DR   HOVERGEN; HBG052338; -.
DR   InParanoid; Q92539; -.
DR   KO; K15728; -.
DR   OMA; FRQWTES; -.
DR   OrthoDB; EOG091G01AU; -.
DR   PhylomeDB; Q92539; -.
DR   TreeFam; TF314095; -.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-1483213; Synthesis of PE.
DR   Reactome; R-HSA-4419969; Depolymerisation of the Nuclear Lamina.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   GenomeRNAi; 9663; -.
DR   PRO; PR:Q92539; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000101577; -.
DR   CleanEx; HS_LPIN2; -.
DR   ExpressionAtlas; Q92539; baseline and differential.
DR   Genevisible; Q92539; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0008195; F:phosphatidate phosphatase activity; EXP:Reactome.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0009062; P:fatty acid catabolic process; IBA:GO_Central.
DR   GO; GO:0006629; P:lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR031703; Lipin_mid.
DR   InterPro; IPR007651; Lipin_N.
DR   InterPro; IPR013209; LNS2.
DR   InterPro; IPR031315; LNS2/PITP.
DR   InterPro; IPR026744; LPIN2.
DR   PANTHER; PTHR12181:SF44; PTHR12181:SF44; 1.
DR   Pfam; PF16876; Lipin_mid; 1.
DR   Pfam; PF04571; Lipin_N; 1.
DR   Pfam; PF08235; LNS2; 1.
DR   SMART; SM00775; LNS2; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Congenital dyserythropoietic anemia; Cytoplasm;
KW   Disease mutation; Endoplasmic reticulum; Fatty acid metabolism;
KW   Hereditary hemolytic anemia; Hydrolase; Lipid metabolism; Membrane;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    896       Phosphatidate phosphatase LPIN2.
FT                                /FTId=PRO_0000209881.
FT   REGION        1    108       N-LIP.
FT   REGION      635    837       C-LIP.
FT   MOTIF       153    158       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF       689    693       DXDXT motif.
FT   MOTIF       700    704       LXXIL motif.
FT   MOD_RES     106    106       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     174    174       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99PI5}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99PI5}.
FT   MOD_RES     187    187       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99PI5}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     303    303       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     566    566       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     734    734       S -> L (in MJDS; dbSNP:rs80338807).
FT                                {ECO:0000269|PubMed:15994876}.
FT                                /FTId=VAR_023817.
SQ   SEQUENCE   896 AA;  99399 MW;  080113FCCA533272 CRC64;
     MNYVGQLAGQ VIVTVKELYK GINQATLSGC IDVIVVQQQD GSYQCSPFHV RFGKLGVLRS
     KEKVIDIEIN GSAVDLHMKL GDNGEAFFVE ETEEEYEKLP AYLATSPIPT EDQFFKDIDT
     PLVKSGGDET PSQSSDISHV LETETIFTPS SVKKKKRRRK KYKQDSKKEE QAASAAAEDT
     CDVGVSSDDD KGAQAARGSS NASLKEEECK EPLLFHSGDH YPLSDGDWSP LETTYPQTAC
     PKSDSELEVK PAESLLRSES HMEWTWGGFP ESTKVSKRER SDHHPRTATI TPSENTHFRV
     IPSEDNLISE VEKDASMEDT VCTIVKPKPR ALGTQMSDPT SVAELLEPPL ESTQISSMLD
     ADHLPNAALA EAPSESKPAA KVDSPSKKKG VHKRSQHQGP DDIYLDDLKG LEPEVAALYF
     PKSESEPGSR QWPESDTLSG SQSPQSVGSA AADSGTECLS DSAMDLPDVT LSLCGGLSEN
     GEISKEKFME HIITYHEFAE NPGLIDNPNL VIRIYNRYYN WALAAPMILS LQVFQKSLPK
     ATVESWVKDK MPKKSGRWWF WRKRESMTKQ LPESKEGKSE APPASDLPSS SKEPAGARPA
     ENDSSSDEGS QELEESITVD PIPTEPLSHG STTSYKKSLR LSSDQIAKLK LHDGPNDVVF
     SITTQYQGTC RCAGTIYLWN WNDKIIISDI DGTITKSDAL GQILPQLGKD WTHQGIAKLY
     HSINENGYKF LYCSARAIGM ADMTRGYLHW VNDKGTILPR GPLMLSPSSL FSAFHREVIE
     KKPEKFKIEC LNDIKNLFAP SKQPFYAAFG NRPNDVYAYT QVGVPDCRIF TVNPKGELIQ
     ERTKGNKSSY HRLSELVEHV FPLLSKEQNS AFPCPEFSSF CYWRDPIPEV DLDDLS
//
